The Texture of Psychoactive Illicit Drugs in Iran: Adulteration with Lead and other Active Pharmaceutical Ingredients

References

• Aghaee-Afshar, M., P. Khazaeli, B. Behnam, M. Rezazadehkermani, and N. Ashraf-Ganjooei. 2008. Presence of lead in opium. Archives of Iranian Medicine 11 (5):553–54.
   PubMedGoogle Scholar
• Akhgari, M., and A. Etemadi-Aleagha. 2016. Organ toxicity associated with illicit drug use. Journal of Clinical Toxicology 6:e125. doi:10.4172/2161-0495.1000e125.
   Google Scholar
• Akhgari, M., A. Etemadi-Aleagha, and F. Jokar. 2016. Street level Heroin, an overview on its components and adulterants. In Neuropathology of drug addictions and substance misuse volume 1: Foundations of understanding, tobacco, alcohol, cannabinoids and opioids, ed. V. R. Preedy, 867–77. UK: Academic Press. doi:10.1016/B978-0-12-800213-1.00081-X.
   Google Scholar
• Akhgari, M., F. Jokar, L. Bahmanabadi, and A. Etemadi Aleagha. 2012. Street-level heroin seizures in Iran: A survey of components. Journal of Substance Use 17 (4):348–55. doi:10.3109/14659891.2011.592898.
   Web of Science ®Google Scholar
• Akhgari, M., F. Jokar, and A. Etemadi Aleagha. 2011. Drug related deaths in Tehran, Iran: Toxicological, death and crime scene investigations. Iranian Journal of Toxicology 5 (1&2):402–09.
   Google Scholar
• Alinejad, S., J. Aaseth, M. Abdollahi, H. Hassanian-Moghaddam, and O. Mehrpour. 2018. Clinical aspects of opium adulterated with lead in Iran: A review. Basic & Clinical Pharmacology & Toxicology 122 (1):56–64. doi:10.1111/bcpt.12855.
   PubMed Web of Science ®Google Scholar
• Allcott, J. V., R. A. Barnhart, and L. A. Mooney. 1987. Acute lead poisoning in two users of illicit methamphetamine. The Journal of the American Medical Association 258 (4):510–11. doi:10.1001/jama.1987.03400040108032.
   Web of Science ®Google Scholar
• Amini, N., A. Etemadi-Aleagha, and M. Akhgari. 2015. Impurity profiling of street methamphetamine samples seized in Kermanshah, Iran with special focus on methamphetamine impurities health hazards. Journal of Clinical Toxicology 5:258. doi:10.4172/2161-0495.1000258.
   Google Scholar
• Andreasen, M. F., C. Lindholst, and E. Kaa. 2009. Adulterants and diluents in heroin, amphetamine, and cocaine found on the illicit drug market in Aarhus, Denmark. The Open Forensic Science Journal 2:16–20. doi:10.2174/1874402800902010016.
   Google Scholar
• Antonini, G., G. Palmieri, E. Millefiorini, L. G. Spagnoli, and M. Millefiorini. 1989. Lead poisoning during heroin addiction. Italian Journal of Neurological Sciences 10 (1):105–08. doi:10.1007/BF02333882.
   PubMedGoogle Scholar
• Broséus, J., N. Gentile, and P. Esseiva. 2016. The cutting of cocaine and heroin: A critical review. Forensic Science International 262:73–83. doi:10.1016/j.forsciint.2016.02.033.
   PubMed Web of Science ®Google Scholar
• Brunt, T. M., C. Nagy, A. Bücheli, D. Martins, M. Ugarte, C. Beduwe, and M. Ventura Vilamala. 2017. Drug testing in Europe: Monitoring results of the Trans European Drug Information (TEDI) project. Drug Testing and Analysis 9 (2):188–98. doi:10.1002/dta.1954.
   PubMed Web of Science ®Google Scholar
• Chia, B. L., C. K. Leng, F. P. Hsii, M. H. Yap, and Y. K. Lee. 1973. Lead poisoning from contaminated opium. British Medical Journal 1:354. doi:10.1136/bmj.1.5849.354-a.
   PubMed Web of Science ®Google Scholar
• Cole, C., L. Jones, J. McVeigh, A. Kicman, Q. Syed, and M. A. Bellis. 2010. CUT: A guide to adulterants, bulking agents and other contaminants found in illicit drugs. Liverpool: Faculty of Health and Applied Social Sciences, Liverpool John Moores University.
   Google Scholar
• Coomber, R. 1997. How often does the adulteration/dilution of heroin actually occur? An analysis of 228 street heroin samples across the UK (1995–96) and discussion of monitoring policy. International Journal of Drug Policy 8 (4):178–86.
   Google Scholar
• de LA Fuente, L., P. Saavedra, G. Barrio, L. Royuela, J. Vicente, R. Alis, A. Balseiro, J. Servera, C. Cordoba, C. Dominguez, J. L. Esquerra, H. Gutierrez, L. Dominguez, M. Repetto, J. Santacreu, L. Senra, A. Vicente, C. Yeregui, and D. Garrido. 1996. Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Drug and Alcohol Dependence 40 (3):185–94.
   PubMed Web of Science ®Google Scholar
• Domeneh, B. H., N. Tavakoli, and N. Jafari. 2014. Blood lead level in opium dependents and its association with anemia: A cross-sectional study from the capital of Iran. Journal of Research in Medical Sciences 19 (10):939–43.
   PubMed Web of Science ®Google Scholar
• Duterte, M., C. Jacinto, P. Sales, and S. Murphy. 2009. What’s in a label? Ecstasy sellers’ perceptions of pill brands. Journal of Psychoactive Drugs 41 (1):27–37. doi:10.1080/02791072.2009.10400672.
   PubMed Web of Science ®Google Scholar
• Eiden, C., C. Diot, O. Mathieu, M. Mallaret, and H. Peyrière. 2014. Levamisole-adulterated cocaine: What about in European countries? Journal of Psychoactive Drugs 46 (5):389–92. doi:10.1080/02791072.2014.959215.
   PubMed Web of Science ®Google Scholar
• Farhoudian, A., M. Sadeghi, H. R. Khoddami Vishteh, B. Moazen, M. Fekri, and A. Rahimi Movaghar. 2014. Component analysis of Iranian Crack; A newly abused narcotic substance in Iran. Iranian Journal of Pharmaceutical Research 13 (1):337–44.
   PubMed Web of Science ®Google Scholar
• FDA. http://www.fda.gov.ir/en/item/2807.
   Google Scholar
• Foroughi, M. H., M. Akhgari, F. Jokar, and Z. Mousavi. 2017. Identification of undeclared active pharmaceutical ingredients in counterfeit herbal medicines used as opioid substitution therapy. Australian Journal of Forensic Sciences 49 (6):720–29. doi:10.1080/00450618.2016.1273387.
   Web of Science ®Google Scholar
• French, H. E., M. J. Went, and S. J. Gibson. 2013. Graphite furnace atomic absorption elemental analysis of ecstasy tablets. Forensic Science International 231 (1–3):88–91. doi:10.1016/j.forsciint.2013.04.021.
   PubMed Web of Science ®Google Scholar
• Ghaemi, K., A. Ghoreishi, N. Rabiee, S. Alinejad, E. Farzaneh, A. Amirabadi Zadeh, M. Abdollahi, and O. Mehrpour. 2017. Blood lead levels in asymptomatic opium addict patients; a case control study. Emergency 5 (1):e69.
   PubMed Web of Science ®Google Scholar
• Ghafari, R., A. Heydari, M. R. Vardast, and A. Akbar. 2014. HPLC measurement of MDMA content in Ecstasy tablets available in the black market of West Azerbaijan Province, Northwestern Iran. Asia Pacific Journal of Medical Toxicology 3 (4):163–68. doi:10.22038/apjmt.2014.3844.
   Google Scholar
• Ghasemi Dastjerdi, A., M. Akhgari, A. Kamali, and Z. Mousavi. 2018. Principal component analysis of synthetic adulterants in herbal supplements advertised as weight loss drugs. Complementary Therapies in Clinical Practice 31:236–41. doi:10.1016/j.ctcp.2018.03.007.
   PubMed Web of Science ®Google Scholar
• Hafizi Fard, H., and M. Akhgari. 2018. Analytical perspectives of chemical adulterants in herbal sexual enhancer drugs. Journal of Pharmacy and Pharmacognosy Research 6 (1):45–53. http://jppres.com/jppres.
   Web of Science ®Google Scholar
• Iqbal, N. 2002. Hearing loss in amphetamine users. Journal of Psychoactive Drugs 34 (4):401–07. doi:10.1080/02791072.2002.10399981.
   PubMed Web of Science ®Google Scholar
• Iravani, F. S., M. Akhgari, F. Jokar, and L. Bahmanabadi. 2010. Current trends in tramadol related fatalities, Tehran, Iran 2005-2008. Substance Use & Misuse 45 (13):2162–71. doi:10.3109/10826081003692098.
   PubMed Web of Science ®Google Scholar
• Jalili, M., and R. Azizkhani. 2009. Lead toxicity resulting from chronic ingestion of opium. Western Journal of Emergency Medicine 10:244–46.
   PubMedGoogle Scholar
• Khajeamiri, A. R., F. Kobarfard, R. Ahmadkhaniha, and G. Mostashari. 2011. Profiling of ecstasy tablets seized in Iran. Iranian Journal of Pharmaceutical Research 10 (2):211–20.
   PubMed Web of Science ®Google Scholar
• Mars, S. G., P. Bourgois, G. Karandinos, F. Montero, and D. Ciccarone. 2016. The textures of Heroin: User Perspectives on “Black Tar” and Powder Heroin in Two U.S. Cities. Journal of Psychoactive Drugs 48 (4):270–78. doi:10.1080/02791072.2016.1207826.
   PubMed Web of Science ®Google Scholar
• Mars, S. G., J. Ondocsin, and D. Ciccarone. 2017. Sold as Heroin: Perceptions and use of an evolving drug in Baltimore, MD. Journal of Psychoactive Drugs 6:1–10. doi:10.1080/02791072.2017.1394508.
   Web of Science ®Google Scholar
• Martello, S., M. Pieri, C. Ialongo, S. Pignalosa, G. Noce, F. Vernich, C. Russo, F. Mineo, S. Bernardini, and L. T. Marsella. 2017. Levamisole in illicit trafficking cocaine seized: A one-year study. Journal of Psychoactive Drugs 49 (5):408–12. doi:10.1080/02791072.2017.1361558.
   PubMedGoogle Scholar
• Mostafazadeh, B., S. Shadnia, M. A. Tavakkoli, and H. R. Khoddami Vishteh. 2017. Evaluation of blood lead level in methamphetamine users in Tehran. Substance Abuse Treatment, Prevention and Policy 12:2. doi:10.1186/s13011-017-0088-3.
   PubMed Web of Science ®Google Scholar
• Noroozi, A., M. Malekinejad, and A. Rahimi-Movaghar. 2018. Factors influencing transition to Shisheh (Methamphetamine) among young people who use drugs in Tehran: A qualitative study. Journal of Psychoactive Drugs 29:1–10. doi:10.1080/02791072.2018.1425808.
   Web of Science ®Google Scholar
• Norton, R. L., B. T. Burton, and J. McGirr. 1996. Blood lead of intravenous drug users. Journal of Toxicology: Clinical Toxicology 34 (4):425–30.
   PubMed Web of Science ®Google Scholar
• Palamar, J. J. 2017. What’s in a Name? correlates of ecstasy users knowing or agreeing that molly is Ecstasy/MDMA. Journal of Psychoactive Drugs 22:1–6. doi:10.1080/02791072.2017.1369200.
   Web of Science ®Google Scholar
• Palma-Conesa, Á. J., M. Ventura, L. Galindo, F. Fonseca, M. Grifell, P. Quintana, I. Fornís, C. Gil, M. Farré, and M. Torrens. 2017. Something new about something old: A 10-year follow-up on classical and new psychoactive tryptamines and results of analysis. Journal of Psychoactive Drugs 49 (4):297–305. doi:10.1080/02791072.2017.1320732.
   PubMed Web of Science ®Google Scholar
• Rigg, K. K. 2017. Motivations for using MDMA (Ecstasy/Molly) among African Americans: Implications for prevention and harm-reduction programs. Journal of Psychoactive Drugs 49 (3):192–200. doi:10.1080/02791072.2017.1305518.
   PubMed Web of Science ®Google Scholar
• Risser, D., A. Uhl, F. Oberndorfer, S. Hönigschnabl, M. Stichenwirth, R. Hirz, and D. Sebald. 2007. Is there a relationship between street heroin purity and drug-related emergencies and/or drug-related deaths? An analysis from Vienna: Austria. Journal of Forensic Sciences 52 (5):1171–76. doi:10.1111/j.1556-4029.2007.00507.x.
   PubMed Web of Science ®Google Scholar
• Safety evaluation of certain food additives and contaminants. World Health Organization. 2011. http://apps.who.int/food-additives-contaminants-jecfadatabase/document.aspx?docID=9003.
   Google Scholar
• Shekari, A., M. Akhgari, F. Jokar, and Z. Mousavi. 2016. Impurity characteristics of street methamphetamine crystals seized in Tehran, Iran. Journal of Substance Use 21 (5):501–05. doi:10.3109/14659891.2015.1068389.
   Web of Science ®Google Scholar
• Simonsen, K. W., E. Kaa, E. Nielsen, and D. Rollmann. 2003. Narcotics at street level in Denmark: A prospective investigation from 1995 to 2000. Forensic Science International 131 (2–3):162–70.
   PubMed Web of Science ®Google Scholar
• Solimini, R., M. C. Rotolo, M. Pellegrini, A. Minutillo, R. Pacifici, F. P. Busardò, and S. Zaami. 2017. Adulteration practices of psychoactive illicit drugs: An updated review. Current Pharmaceutical Biotechnology 18 (7):524–30. doi:10.2174/1389201018666170710184531.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2004. Neuroscience of psychoactive substance use and dependence. Geneva: World Health Organization.
   Google Scholar
• Zamani, N., and H. Hassanian-Moghaddam. 2018. Notes from the Field: Lead Contamination of Opium — Iran, 2016. Morbidity and Mortality Weekly Report (MMWR) 66 (5152):1408–09. doi:10.15585/mmwr.mm665152a4.
   PubMed Web of Science ®Google Scholar